September 19, 2019
Rose
The drug--which contains low doses of three blood pressure drugs and a cholesterol drug--has been tested in the United States for the first time. But many U.S. doctors have seen little need for the polypill, preferring to tailor medications individually.
from Kaiser Health News https://ift.tt/31BhpUj
September 19, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Vermont’s Successful Experiment To Lower Health Costs Closely Watched By Other States, Experts- First, Marijuana. Are Magic Mushrooms Next?
- State Requests For Medicaid Work Requirement Seem Like A Sure Bet. But CMS Says ‘Not So Fast’ To Some.
- Sticker Shock Jolts Oklahoma Patient: $15,076 For Four Tiny Screws
- First Edition: May 14, 2018
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment